Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and netilmicin

moxifloxacin has been researched along with netilmicin in 7 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(netilmicin)		Trials
(netilmicin)		Recent Studies (post-2010) (netilmicin)
3,1575521,6901,10819055

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)netilmicin (IC50)
30S ribosomal protein S6Escherichia coli K-120.02
30S ribosomal protein S7Escherichia coli K-120.02
50S ribosomal protein L15Escherichia coli K-120.02
50S ribosomal protein L10Escherichia coli K-120.02
50S ribosomal protein L11Escherichia coli K-120.02
50S ribosomal protein L7/L12Escherichia coli K-120.02
50S ribosomal protein L19Escherichia coli K-120.02
50S ribosomal protein L1Escherichia coli K-120.02
50S ribosomal protein L20Escherichia coli K-120.02
50S ribosomal protein L27Escherichia coli K-120.02
50S ribosomal protein L28Escherichia coli K-120.02
50S ribosomal protein L29Escherichia coli K-120.02
50S ribosomal protein L31Escherichia coli K-120.02
50S ribosomal protein L31 type BEscherichia coli K-120.02
50S ribosomal protein L32Escherichia coli K-120.02
50S ribosomal protein L33Escherichia coli K-120.02
50S ribosomal protein L34Escherichia coli K-120.02
50S ribosomal protein L35Escherichia coli K-120.02
50S ribosomal protein L36Escherichia coli K-120.02
30S ribosomal protein S10Escherichia coli K-120.02
30S ribosomal protein S11Escherichia coli K-120.02
30S ribosomal protein S12Escherichia coli K-120.02
30S ribosomal protein S13Escherichia coli K-120.02
30S ribosomal protein S16Escherichia coli K-120.02
30S ribosomal protein S18Escherichia coli K-120.02
30S ribosomal protein S19Escherichia coli K-120.02
30S ribosomal protein S20Escherichia coli K-120.02
30S ribosomal protein S2Escherichia coli K-120.02
30S ribosomal protein S3Escherichia coli K-120.02
30S ribosomal protein S4Escherichia coli K-120.02
30S ribosomal protein S5Escherichia coli K-120.02
30S ribosomal protein S8Escherichia coli K-120.02
30S ribosomal protein S9Escherichia coli K-120.02
50S ribosomal protein L13Escherichia coli K-120.02
50S ribosomal protein L14Escherichia coli K-120.02
50S ribosomal protein L16Escherichia coli K-120.02
50S ribosomal protein L23Escherichia coli K-120.02
30S ribosomal protein S15Escherichia coli K-120.02
50S ribosomal protein L17Escherichia coli K-120.02
50S ribosomal protein L21Escherichia coli K-120.02
50S ribosomal protein L30Escherichia coli K-120.02
50S ribosomal protein L6Escherichia coli K-120.02
30S ribosomal protein S14Escherichia coli K-120.02
30S ribosomal protein S17Escherichia coli K-120.02
30S ribosomal protein S1Escherichia coli K-120.02
50S ribosomal protein L18Escherichia coli K-120.02
50S ribosomal protein L2Escherichia coli K-120.02
50S ribosomal protein L3Escherichia coli K-120.02
50S ribosomal protein L24Escherichia coli K-120.02
50S ribosomal protein L4Escherichia coli K-120.02
50S ribosomal protein L22Escherichia coli K-120.02
50S ribosomal protein L5Escherichia coli K-120.02
30S ribosomal protein S21Escherichia coli K-120.02
50S ribosomal protein L25Escherichia coli K-120.02
50S ribosomal protein L36 2Escherichia coli K-120.02

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Courvalin, P; Galimand, M; Périchon, B1
Lombardo, F; Obach, RS; Waters, NJ1
Cattoir, V; Nordmann, P; Poirel, L1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Carelli, R; Forte, R; Magli, A; Rombetto, L1
Blanco, AR; Papa, V; Spoto, CG; Sudano Roccaro, A1

Other Studies

7 other study(ies) available for moxifloxacin and netilmicin

ArticleYear
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery.
    International ophthalmology, 2012, Volume: 32, Issue:1

    Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Follow-Up Studies; Humans; Hyperopia; Keratitis; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Netilmicin; Ophthalmic Solutions; Photorefractive Keratectomy; Quinolines; Staphylococcal Infections; Visual Acuity

2012
Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.
    Current eye research, 2013, Volume: 38, Issue:8

    Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Chloramphenicol; Drug Resistance; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Netilmicin; Quinolines; Staphylococcus epidermidis; Tobramycin; Vancomycin

2013